4//SEC Filing
Schilke Tobin 4
Accession 0000950170-25-037200
CIK 0001658247other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:30 PM ET
Size
7.2 KB
Accession
0000950170-25-037200
Insider Transaction Report
Form 4
Schilke Tobin
Chief Financial Officer
Transactions
- Award
Common Stock
2025-03-10+52,000→ 52,000 total - Award
Stock Option (Right to Buy)
2025-03-10+80,000→ 80,000 totalExercise: $33.75Exp: 2035-03-09→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 1, 2026.
- [F2]The option is exercisable as follows: 25% of the shares subject to the option vest on February 28, 2026, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001678984
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:30 PM ET
- Size
- 7.2 KB